TY - JOUR
T1 - Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation
AU - Kim, Won Ho
AU - Shin, Sanghoon
AU - Ko, Young Guk
AU - Hong, Myeong Ki
AU - Jang, Yangsoo
AU - Choi, Donghoon
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2013/6
Y1 - 2013/6
N2 - Purpose: To evaluate in a large patient cohort the 6-F Perclose ProGlide in conjunction with the preclose technique to seal puncture sites after percutaneous endovascular aortic repairs. Methods: The medical records were reviewed of 367 patients (303 men; mean age 68.5±10.8 years) having 599 access site closures with the 6-F Perclose ProGlide performed in conjunction with percutaneous endovascular aortic repairs. Procedure success was defined as hemostasis with the preclose technique without the need for any ancillary procedure. Access-related major adverse events included infection, bleeding, lower leg ischemia, hematoma, pseudoaneurysm, arteriovenous fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death owing to an access site injury. Results: Procedure success was achieved in 359 (97.8%) of 367 patients and in 591 (98.7%) of 599 femoral sites. Access-related major adverse events developed in 25 (6.8%) of 367 patients [26/599 (4.3%) sites]. The most frequent adverse event was a hematoma [16/367 (4.4%) patients; 17/599 (2.8% ) sites], followed by pseudoaneurysm [7/367 (1.9%) patients; 7/599 (1.2%) sites]. Bleeding occurred in 6 (1.6%) of 367 patients [6/599 (1.0%) sites]. There were 2 infections, 2 distal embolizations, 1 acute femoral thrombosis, and 1 laceration at the puncture site. Conclusion: The preclose technique can be used to achieve hemostasis with remarkable success and low rates of adverse events.
AB - Purpose: To evaluate in a large patient cohort the 6-F Perclose ProGlide in conjunction with the preclose technique to seal puncture sites after percutaneous endovascular aortic repairs. Methods: The medical records were reviewed of 367 patients (303 men; mean age 68.5±10.8 years) having 599 access site closures with the 6-F Perclose ProGlide performed in conjunction with percutaneous endovascular aortic repairs. Procedure success was defined as hemostasis with the preclose technique without the need for any ancillary procedure. Access-related major adverse events included infection, bleeding, lower leg ischemia, hematoma, pseudoaneurysm, arteriovenous fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death owing to an access site injury. Results: Procedure success was achieved in 359 (97.8%) of 367 patients and in 591 (98.7%) of 599 femoral sites. Access-related major adverse events developed in 25 (6.8%) of 367 patients [26/599 (4.3%) sites]. The most frequent adverse event was a hematoma [16/367 (4.4%) patients; 17/599 (2.8% ) sites], followed by pseudoaneurysm [7/367 (1.9%) patients; 7/599 (1.2%) sites]. Bleeding occurred in 6 (1.6%) of 367 patients [6/599 (1.0%) sites]. There were 2 infections, 2 distal embolizations, 1 acute femoral thrombosis, and 1 laceration at the puncture site. Conclusion: The preclose technique can be used to achieve hemostasis with remarkable success and low rates of adverse events.
UR - http://www.scopus.com/inward/record.url?scp=84878935240&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878935240&partnerID=8YFLogxK
U2 - 10.1583/12-4103MR2.1
DO - 10.1583/12-4103MR2.1
M3 - Article
C2 - 23731308
AN - SCOPUS:84878935240
VL - 20
SP - 350
EP - 355
JO - Journal of Endovascular Therapy
JF - Journal of Endovascular Therapy
SN - 1526-6028
IS - 3
ER -